| 1 |
35165269 | The synergistic antitumor effect of IL-6 neutralization with NVP-BEZ235 in hepatocellular carcinoma. | 2022 Feb 14 |
2 |
| 2 |
31781916 | The beneficial role of SIRT1 activator on chemo- and radiosensitization of breast cancer cells in response to IL-6. | 2020 Jan |
1 |
| 3 |
29653746 | SRT1720, a potential sensitizer for radiotherapy and cytotoxicity effects of NVB-BEZ235 in metastatic breast cancer cells. | 2018 Jun |
1 |
| 4 |
25216518 | Dual PI3K/mTOR inhibition is required to effectively impair microenvironment survival signals in mantle cell lymphoma. | 2014 Aug 30 |
1 |
| 5 |
19584292 | Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235. | 2009 Jul 15 |
1 |